a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, has been named a Concept Stage winner of the United States Biomedical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback